Stock 002349 JINGHUA PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jinghua Pharmaceutical Group Co., Ltd.

Equities

002349

CNE100000L14

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7.88 CNY +0.13% Intraday chart for Jinghua Pharmaceutical Group Co., Ltd. +3.55% -11.16%
Apr. 29 Jinghua Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Jinghua Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

JINGHUA PHARMACEUTICAL GROUP CO., LTD., formerly NANTONG JINGHUA PHARMACEUTICAL CO., LTD., is a China-based company, principally engaged in the research and development, production and distribution of Chinese patent drugs, pharm ingredients and intermediates and chemical intermediates. The Company is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The Company primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The Company offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The Company distributes its products in domestic and overseas markets.

Number of employees: 1,641

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicine Preparations
32.5 %
419 26.6 % 491 32.5 % +17.26%
Chemical and Pharmaceutical Intermediates
29.7 %
469 29.8 % 449 29.7 % -4.42%
Chemical Raw Materials and Pharmaceutical Intermediates
22.5 %
337 21.4 % 340 22.5 % +0.90%
Chinese Herbal Medicines and Chinese Herbal Medicine Pieces
14.7 %
135 8.6 % 223 14.7 % +64.63%
Others
0.6 %
212 13.5 % 9 0.6 % -95.73%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
89.8 %
1,404 89.2 % 1,357 89.8 % -3.34%
International
10.2 %
169 10.8 % 155 10.2 % -8.54%

Managers

Managers TitleAgeSince
Yun Zhong Zhou CEO
 Chief Executive Officer 60 13-11-17
Yu Xiang Wu DFI
 Director of Finance/CFO 55 21-02-07
Jian Qin COO
 Chief Operating Officer 50 17-08-27
Yi Qiu Fan IRC
 Investor Relations Contact - -
Jian Feng Wang SEC
 Corporate Secretary 47 -

Members of the board

Members of the board TitleAgeSince
Yun Zhong Zhou CEO
 Chief Executive Officer 60 13-11-17
Qiao Gen Feng BRD
 Director/Board Member 63 19-11-12
Hong Wei Xue CHM
 Chairman 58 17-03-02
Jian Qin COO
 Chief Operating Officer 50 17-08-27
Hong Yu Yin CHM
 Chairman 51 19-04-21
Jian Qiao Zhang BRD
 Director/Board Member 50 20-04-26
Xu Wang BRD
 Director/Board Member 73 21-04-26
Ling Ma BRD
 Director/Board Member 53 21-02-07
Yu Xiang Wu DFI
 Director of Finance/CFO 55 21-02-07
Chen Guang Dai BRD
 Director/Board Member 35 22-04-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 814,180,908 488,417,165 ( 59.99 %) 0 59.99 %

Shareholders

NameEquities%Valuation
Nantong State-Owned Assets Supervision & Administration
34.18 %
279,996,600 34.18 % 306 M ¥
Sheng Da Zan
3.232 %
26,471,323 3.232 % 29 M ¥
Jiangsu Variety Holdings Group Co. Ltd.
1.988 %
16,283,600 1.988 % 18 M ¥
Penghua Fund Management Co., Ltd.
0.1179 %
966,000 0.1179 % 1 M ¥
China Merchants Fund Management Co., Ltd.
0.1159 %
949,500 0.1159 % 1 M ¥
China Asset Management Co., Ltd.
0.0976 %
799,200 0.0976 % 873 566 ¥
China Southern Asset Management Co., Ltd.
0.0864 %
707,700 0.0864 % 773 551 ¥
Fullgoal Fund Management Co., Ltd.
0.0520 %
425,900 0.0520 % 465 530 ¥
GF Fund Management Co., Ltd.
0.0433 %
354,800 0.0433 % 387 814 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0195 %
160,000 0.0195 % 174 888 ¥

Company contact information

Jinghua Pharmaceutical Group Co., Ltd.

20-25/F, Bldg A, 198 Qingnian Middle Guocheng Life Plaza Office Building

226001, Nantong

+

http://www.ntjhzy.com
address Jinghua Pharmaceutical Group Co., Ltd.(002349)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
JINGHUA PHARMACEUTICAL GROUP CO., LTD. Stock Jinghua Pharmaceutical Group Co., Ltd.
-11.16% 886M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.03% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.70% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.13% 326B
ABBVIE INC. Stock AbbVie Inc.
+2.68% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-4.44% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002349 Stock
  4. Company Jinghua Pharmaceutical Group Co., Ltd.